Abstract
The article presents data from our ownstudies on the clinical course of COVID-19 in patientswith ankylosing spondylitis while receiving basic therapy. Patients were divided into groups:those who underwent COVID-19 against the background of basic therapy and without it. Theimpact of COVID-19 was compared with clinical symptoms, disease activity. According to theresults of the studies, a positive effect of basic antirheumatic therapy on the course ofcoronavirus infection in patients with ankylosing spondylitis was revealed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: ACADEMICIA: An International Multidisciplinary Research Journal
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
